Assembly Biosciences ASMB
NASDAQ ASMB
$22.10 -0.27 (-1.21%)
As of: Nov 12, 2026 · 9:30 AM EST

Assembly Biosciences (ASMB) Return on Sales [ROS] (2010 - 2026)

Updated

Assembly Biosciences' Return on Sales [ROS] came in at -47.44% for Q2 2026, up 67.80 percentage points from -115.24% a year earlier and up 91.00 percentage points from the prior quarter.

Analysis

Assembly Biosciences (ASMB) Return on Sales [ROS] (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Assembly Biosciences reported Return on Sales [ROS] of -11.75%, up 119.15 percentage points year-over-year; for FY2025, it came in at -16.76%, up 142.50 percentage points from FY2024.

  • Return on Sales [ROS] carries a five-year change of +65.13 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Sales [ROS] was -159.26% in FY2024 (+743.24 pp), -902.50% in FY2023 and -2121.65% in FY2021 (-2039.76 pp).
  • The five-year range for quarterly Return on Sales [ROS] is -2121.65% (Q4 2021) to 46.62% (Q4 2025).
  • Year-over-year, Return on Sales [ROS] increased in six of the last seven quarters, with an average year-over-year change of +60.52 percentage points.
  • The fastest year-over-year change in Return on Sales [ROS] over five years came in Q4 2021 (a gain of 1701.11 percentage points), and the weakest in Q3 2021 (a drop of 290.19 percentage points).
  • Business Quant data shows ASMB's Return on Sales [ROS] at -138.44% (Q1 2026), 46.62% (Q4 2025) and -100.87% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Assembly Biosciences 423.80 Mn -603.82 Mn - -47.44%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -47.44%
Mar 31, 2026 -138.44%
Dec 31, 2025 46.62%
Sep 30, 2025 -100.87%
Jun 30, 2025 -115.24%
Mar 31, 2025 -105.54%
Dec 31, 2024 -156.75%
Sep 30, 2024 -160.06%
Jun 30, 2024 -143.01%
Mar 31, 2024 -185.46%
Dec 31, 2023 -175.22%
Jun 30, 2023 -1,333.96%
Mar 31, 2023 -1,447.25%
Dec 31, 2021 -2,121.65%
Sep 30, 2021 -301.81%
Jun 30, 2021 -265.33%
Mar 31, 2021 -85.76%
Dec 31, 2020 -3,822.76%
Sep 30, 2020 -11.61%
Jun 30, 2020 16.71%
API Access

Assembly Biosciences Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ASMB&period=max&api_key=YOUR_API_KEY